Don’t panic, but tiny mites are likely living on your body. Although this might be disturbing news, don’t stress. It’s quite common for all people to have some Demodex mites since they naturally occur ...

(Yicai) March 23 -- Shares in Grand Pharma tumbled today despite the Chinese drugmaker being given the greenlight to take its first-in-class eye treatment for demodex blepharitis, a chronic eyelid ...

The standard of care for Demodex blepharitis has improved substantially. The current approach involves both identifying and treating the condition effectively. Patients with Demodex blepharitis may ...

XDEMVY is the first and only approved therapeutic for Demodex blepharitis, a highly prevalent eyelid disease that impacts approximately 25 million eye care patients in the U.S. XDEMVY targets the root ...

Modern Vision Solutions has announced the publication of a new article, “Demodex Blepharitis Treatment in Omaha,” highlighting a significant shift in how optometrists approach the treatment of chronic ...

IRVINE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven ...

Credit: Tarsus Pharmaceuticals. Xdemvy is supplied as an ophthalmic solution containing lotilaner 0.25% (2.5mg/mL) in a 10mL bottle; it is expected to be available by the end of August 2023. The Food ...

Add Yahoo as a preferred source to see more of our stories on Google. I often see patients with rosacea, a chronic skin condition that causes redness, swelling and sometimes bumps on the face. While ...

The FDA approved lotilaner ophthalmic solution 0.25% (Xdemvy) as the first specific treatment for Demodex blepharitis. Lotilaner (formerly TP-03) is an ectoparasiticide that targets Demodex mites, ...

In better news: They're totally treatable and actually pretty common (especially for makeup wearers).